Phase II study of nivolumab and salvage nivolumab/ipilimumab in treatment-naïve patients with advanced non-clear cell renal cell carcinoma (HCRN GU16-260-Cohort B).
Michael B AtkinsOpeyemi A JegedeNaomi B HaasDavid F McDermottMehmet Asim BilenMark SteinJeffrey A SosmanRobert AlterElizabeth R PlimackMoshe C OrnsteinMichael HurwitzDavid J PeaceSabina SignorettiThomas DenizeAlessia CimadamoreCatherine J WuDavid A BraunDavid EinsteinPaul J CatalanoHans HammersPublished in: Journal for immunotherapy of cancer (2023)
NCT03117309.